Sunmax Biotechnology Co Ltd (4728) — Capital Reinvestment Ratio
Sunmax Biotechnology Co Ltd (4728) has a Capital Reinvestment Ratio of 0.11x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$160.84 Million) in capital expenditures (NT$17.44 Million). See Sunmax Biotechnology Co Ltd (4728) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sunmax Biotechnology Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Sunmax Biotechnology Co Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Sunmax Biotechnology Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Sunmax Biotechnology Co Ltd from 2016 to 2024. For live market cap and broader valuation context, see Sunmax Biotechnology Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | NT$397.37 Million | NT$36.61 Million | ▼ -29.2% |
| 2023 | 0.13x | NT$848.56 Million | NT$110.39 Million | ▼ -70.7% |
| 2022 | 0.44x | NT$342.97 Million | NT$152.03 Million | ▼ -57.8% |
| 2021 | 1.05x | NT$243.28 Million | NT$255.43 Million | ▲ +212.3% |
| 2020 | 0.34x | NT$386.97 Million | NT$130.10 Million | ▲ +611.3% |
| 2019 | 0.05x | NT$289.51 Million | NT$13.68 Million | ▲ +1.0% |
| 2018 | 0.05x | NT$100.83 Million | NT$4.72 Million | ▼ -45.0% |
| 2017 | 0.09x | NT$37.09 Million | NT$3.15 Million | ▼ -70.2% |
| 2016 | 0.29x | NT$16.58 Million | NT$4.73 Million | — |